Ombow, Just look at the headline of that article -
"Leronlimab Trial Results All But Certain Pointing to Approval For CytoDyn"
Then look at the picture above it, with throngs of hands throwing their face masks skyward in glee.
This is an obvious puff piece, and is as slanted to the bullish side as what Feuerstein does on the short side.
Personally I would stay far away from this stock. The market cap is already big (2.7 bil), which makes for big potential downside. The stock is surrounded by all kinds of crooked vultures, including the CEO. Covid cases are already starting to decline, and the whole thing will be history by summer. Covid plays were for last year.
There are plenty of other stocks and sectors out there. I would replace 'get rich quick' with a balanced approach.
